首页 | 本学科首页   官方微博 | 高级检索  
     

辛伐他汀治疗不稳定性心绞痛的临床观察
引用本文:李媛,田文华,王莉. 辛伐他汀治疗不稳定性心绞痛的临床观察[J]. 心血管康复医学杂志, 2005, 14(2): 137-139
作者姓名:李媛  田文华  王莉
作者单位:陕西省人民医院老年心血管科,陕西,西安市,710068
摘    要:目的:探讨口服辛伐他汀早期治疗不稳定性心绞痛(UAP)对血脂及缺血事件发生的影响。方法:85例UAP 患者被随机分为治疗组(常规治疗外加服辛伐他汀,44例)和对照组(仅常规治疗,41例),于治疗前,治疗后6个月观察血脂水平及缺血事件发生率。结果:①对照组治疗前、后血脂水平无显著性变化(P>0.05),治疗组治疗后血脂水平明显下降(P<0.05);②治疗组的缺血事件明显少于对照组(P<0.05)。结论:辛伐他汀可明显降低不稳定型心绞痛患者血脂水平及缺血事件发生率。

关 键 词:不稳定性心绞痛 辛伐他汀 血脂 治疗 临床观察
文章编号:1008-0074(2005)02-0137-03
修稿时间:2004-09-24

Effectiveness of simvastatin in the early treatment of unstable angina pectoris
LI Yuan,TIAN Wen-hua,WANG Li. Effectiveness of simvastatin in the early treatment of unstable angina pectoris[J]. Chinese Journal of Cardiovascular Rehabilitation Medicine, 2005, 14(2): 137-139
Authors:LI Yuan  TIAN Wen-hua  WANG Li
Affiliation:LI Yuan,TIAN Wen-hua,WANG Li Department of Geriatric Cardiology,Shanxi Provincial People's Hospital,Xi'an,Shanxi,710068
Abstract:Objective:To evaluate the efficacy of simvastatin early treatment of patients with unstable angina pectoris (UAP). Methods: Eighty-five subjects were randomly divided into simvastatin group and control group. They all underwent blood lipid monitoring and observation of ischemic events before therapy and six months after therapy. Results:Compared with the baseline values, after six months treatment, there was a significant reduction of blood lipid levels in simvastatin group (P<0. 05), but without statistic difference in control group (P>0. 05). During the six months of follow-up, fewer ischemic events occurred in the simvastatin group (P<0. 05). Conclusion: Simvastatin can significantly reduce blood lipid levels and the incidence of ischemic events.
Keywords:Unstable angina pectoris  Simvastatin  Blood lipid
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号